+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Conjunctivitis Therapeutics Market 2019-2023 - Product Image

Global Conjunctivitis Therapeutics Market 2019-2023

  • ID: 4751594
  • Report
  • February 2019
  • Region: Global
  • 115 pages
  • TechNavio
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 4

Enquire about COVID-19 updates for this product.

Enquire Now

FEATURED COMPANIES

  • Akorn Incorporated
  • ALLERGAN
  • Bausch Health
  • Novartis AG
  • MORE
Conjunctivitis is inflammation in the inside of the eyelids and the covering of the white of the eye, which causes the conjunctival blood vessels to dilate. While allergic conjunctivitis is known to be prevalent among people with allergies, infectious conjunctivitis is known to spread at a very fast rate. The ease of availability of antibiotic eye drops and ointments for the treatment of bacterial conjunctivitis and antibiotics for viral conjunctivitis is leading to an increase in the use of these therapeutics. The use of therapeutics is primarily to avoid the progression of the disease into severe indications, which could increase the economic burden of patients. Hence, the infectious nature of the disease is expected to increase the adoption rate of therapeutics, thus resulting in the growth of the market during the forecast period. The analysts have predicted that the conjunctivitis therapeutics market will register a CAGR of over 8% by 2023.

Market Overview

Growing allergy cases

Allergic conjunctivitis is caused by various types of allergies such as hay fever and asthma. Being allergic to substances such as dust mites and mold can also increase the risk of infection. Globally, the prevalence of various types of allergies has been growing at a significant rate. The increasing prevalence of allergies such as dust mite allergy and pollen allergy increase the risk of allergic conjunctivitis.

Patent cliff

One of the major challenges faced by the global conjunctivitis therapeutics market is the patent expiration of various drugs in the market. Patent expiration leads to the increasing launch of generic drugs, thereby leading to value erosion of the global market. The patent expiry of blockbuster drugs also impacts the sales of the vendors significantly, making it difficult for vendors to compete in the market. Thus, the patent expiry of blockbuster drugs and the subsequent entry of generics restrict market growth.

For the detailed list of factors that will drive and challenge the growth of the conjunctivitis therapeutics market during the 2019-2023, view this report.

Competitive Landscape

The market appears to be concentrated and with the presence of very few vendors. This market research report will help clients identify new growth opportunities and design unique growth strategies by providing a comprehensive analysis of the market’s competitive landscape and offering information on the products offered by companies.
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Akorn Incorporated
  • ALLERGAN
  • Bausch Health
  • Novartis AG
  • MORE
PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT
  • Preface
  • Currency conversion rates for US$
PART 03: MARKET LANDSCAPE
  • Market ecosystem
  • Market characteristics
  • Market segmentation analysis
PART 04: MARKET SIZING
  • Market definition
  • Market sizing 2018
  • Market size and forecast 2018-2023
PART 05: FIVE FORCES ANALYSIS
  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition
PART 06: MARKET SEGMENTATION BY TYPE
  • Market segmentation by type
  • Comparison by type
  • Allergic conjunctivitis - Market size and forecast 2018-2023
  • Bacterial conjunctivitis - Market size and forecast 2018-2023
  • Viral conjunctivitis - Market size and forecast 2018-2023
  • Market opportunity by type
PART 07: CUSTOMER LANDSCAPE

PART 08: GEOGRAPHIC LANDSCAPE
  • Geographic segmentation
  • Geographic comparison
  • North America - Market size and forecast 2018-2023
  • Europe - Market size and forecast 2018-2023
  • Asia - Market size and forecast 2018-2023
  • ROW - Market size and forecast 2018-2023
  • Key leading countries
  • Market opportunity
PART 09: DRIVERS AND CHALLENGES
  • Market drivers
  • Market challenges
PART 10: MARKET TRENDS

PART 11: VENDOR LANDSCAPE
  • Overview
  • Landscape disruption
  • Competitive scenario
PART 12: VENDOR ANALYSIS
  • Vendors covered
  • Vendor classification
  • Market positioning of vendors
  • Akorn, Incorporated
  • ALLERGAN
  • Bausch Health
  • Novartis AG
  • Santen Pharmaceutical Co., Ltd.
PART 13: APPENDIX
  • Research methodology
  • List of abbreviations
List of Exhibits
Exhibit 01: Years in consideration
Exhibit 02: Global pharmaceuticals market
Exhibit 03: Segments of global pharmaceuticals market
Exhibit 04: Market characteristics
Exhibit 05: Market segments
Exhibit 06: Market definition - Inclusions and exclusions checklist
Exhibit 07: Market size 2018
Exhibit 08: Global market: Size and forecast 2018-2023 ($ millions)
Exhibit 09: Global market: Year-over-year growth 2019-2023 (%)
Exhibit 10: Five forces analysis 2018
Exhibit 11: Five forces analysis 2023
Exhibit 12: Bargaining power of buyers
Exhibit 13: Bargaining power of suppliers
Exhibit 14: Threat of new entrants
Exhibit 15: Threat of substitutes
Exhibit 16: Threat of rivalry
Exhibit 17: Market condition - Five forces 2018
Exhibit 18: Type - Market share 2018-2023 (%)
Exhibit 19: Comparison by type
Exhibit 20: Allergic conjunctivitis - Market size and forecast 2018-2023 ($ millions)
Exhibit 21: Allergic conjunctivitis - Year-over-year growth 2019-2023 (%)
Exhibit 22: Bacterial conjunctivitis - Market size and forecast 2018-2023 ($ millions)
Exhibit 23: Bacterial conjunctivitis - Year-over-year growth 2019-2023 (%)
Exhibit 24: Viral conjunctivitis - Market size and forecast 2018-2023 ($ millions)
Exhibit 25: Viral conjunctivitis - Year-over-year growth 2019-2023 (%)
Exhibit 26: Market opportunity by type
Exhibit 27: Customer landscape
Exhibit 28: Market share by geography 2018-2023 (%)
Exhibit 29: Geographic comparison
Exhibit 30: North America - Market size and forecast 2018-2023 ($ millions)
Exhibit 31: North America - Year-over-year growth 2019-2023 (%)
Exhibit 32: Europe - Market size and forecast 2018-2023 ($ millions)
Exhibit 33: Europe - Year-over-year growth 2019-2023 (%)
Exhibit 34: Asia - Market size and forecast 2018-2023 ($ millions)
Exhibit 35: Asia - Year-over-year growth 2019-2023 (%)
Exhibit 36: ROW - Market size and forecast 2018-2023 ($ millions)
Exhibit 37: ROW - Year-over-year growth 2019-2023 (%)
Exhibit 38: Key leading countries
Exhibit 39: Market opportunity
Exhibit 40: Decision framework
Exhibit 41: Impact of drivers and challenges
Exhibit 42: Vendor landscape
Exhibit 43: Landscape disruption
Exhibit 44: Vendors covered
Exhibit 45: Vendor classification
Exhibit 46: Market positioning of vendors
Exhibit 47: Akorn, Incorporated - Vendor overview
Exhibit 48: Akorn, Incorporated - Business segments
Exhibit 49: Akorn, Incorporated - Organizational developments
Exhibit 50: Akorn, Incorporated - Segment focus
Exhibit 51: Akorn, Incorporated - Key offerings
Exhibit 52: Akorn, Incorporated - Key customers
Exhibit 53: ALLERGAN - Vendor overview
Exhibit 54: ALLERGAN - Product segments
Exhibit 55: ALLERGAN - Organizational developments
Exhibit 56: ALLERGAN - Geographic focus
Exhibit 57: ALLERGAN - Segment focus
Exhibit 58: ALLERGAN - Key offerings
Exhibit 59: ALLERGAN - Key customers
Exhibit 60: Bausch Health - Vendor overview
Exhibit 61: Bausch Health - Business segments
Exhibit 62: Bausch Health - Organizational developments
Exhibit 63: Bausch Health - Geographic focus
Exhibit 64: Bausch Health - Segment focus
Exhibit 65: Bausch Health - Key offerings
Exhibit 66: Bausch Health - Key customers
Exhibit 67: Novartis AG - Vendor overview
Exhibit 68: Novartis AG - Business segments
Exhibit 69: Novartis AG - Organizational developments
Exhibit 70: Novartis AG - Geographic focus
Exhibit 71: Novartis AG - Segment focus
Exhibit 72: Novartis AG - Key offerings
Exhibit 73: Novartis AG - Key customers
Exhibit 74: Santen Pharmaceutical Co., Ltd. - Vendor overview
Exhibit 75: Santen Pharmaceutical Co., Ltd. - Business segments
Exhibit 76: Santen Pharmaceutical Co., Ltd. - Organizational developments
Exhibit 77: Santen Pharmaceutical Co., Ltd. - Geographic focus
Exhibit 78: Santen Pharmaceutical Co., Ltd. - Segment focus
Exhibit 79: Santen Pharmaceutical Co., Ltd. - Key offerings
Exhibit 80: Santen Pharmaceutical Co., Ltd. - Key customers
Exhibit 81: Validation techniques employed for market sizing
Exhibit 82: List of abbreviations
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4

FEATURED COMPANIES

  • Akorn Incorporated
  • ALLERGAN
  • Bausch Health
  • Novartis AG
  • MORE
Global Conjunctivitis Therapeutics Market 2019-2023

The analyst recognizes the following companies as the key players in the global conjunctivitis therapeutics market: Akorn, Incorporated, ALLERGAN, Bausch Health, Novartis AG, Santen Pharmaceutical Co., Ltd.

Commenting on the report, an analyst from the research team said: “The latest trend gaining momentum in the market is the seasonal nature conjunctivitis is expected to drive the sales of the market during our forecast period.”

According to the report, one of the major drivers for this market is the infectious nature of the disease is expected to increase the adoption rate of therapeutics, thus resulting in the growth of the market during the forecast period.

Further, the report states that one of the major factors hindering the growth of this market is the self- limiting nature of conjunctivitis.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Note: Product cover images may vary from those shown
5 of 4
  • Akorn Incorporated
  • ALLERGAN
  • Bausch Health
  • Novartis AG
  • Santen Pharmaceutical Co. Ltd.
Note: Product cover images may vary from those shown
Adroll
adroll